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Abstract
Background: There is a high unmet need for modern contraception among adolescents, and adolescent girls who
have already been pregnant are especially vulnerable to a rapid, repeat pregnancy (defined as a subsequent pregnancy
within two years). The Adolescent Health Experience after Abortion or Delivery (AHEAD) trial will design, pilot, finalize,
and ultimately evaluate an intervention targeted at reducing rapid repeat pregnancy. This protocol presents the
methods for the first phase–formative research to identify key determinants of contraceptive use and rapid, repeat
unintended pregnancy among adolescents.
Methods/design: The determinants of adolescent pregnancy are known to vary by context; therefore, a dissimilar set
of three countries will be selected to enable evaluation of the intervention in diverse cultural, political and economic
environment, and to allow the intervention to be tested with a fuller range of ever-pregnant adolescents, including
those who have chosen to terminate their pregnancy as well as those who are mothers. We will also consider marital
status in settings where it is common for adolescents to marry. Focus group discussions (FGDs) will be conducted to
examine barriers and facilitators to using contraception; preferred methods of overcoming these barriers; and
perceptions of the services and information received. Key informant (KI) interviews will take place with various cadres
of healthcare providers, health and education officials, and members of key youth and health organizations that work
with adolescents. These interviews will focus on perceptions of pregnant adolescents; perceived information, skills, and
motivations required for adolescent uptake of contraception; and experiences, challenges, and attitudes encountered
during interactions.
Discussion: The findings from this first formative phase will be used to develop an intervention for preventing
rapid, repeat unintended pregnancy among adolescents. This intervention will be piloted in a second phase
of the AHEAD trial.
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Background
The safety and efficacy of contraception for all women,
including adolescents, has been well established [1].
However, high unmet need for modern contraception
persists among adolescents in many low- and middle-
income countries [2, 3]. A recent analysis of trends in
unmet need for contraception among young women
(ages 15–24) demonstrated high unmet need among
with significant regional variations [2] Unmet need
among sexually active, unmarried women ages 15–24
ranges from a low of 7.3 % in the Ukraine to a high of
69.5 % in Senegal [2].
Adolescents face a variety of interrelated barriers to
contraceptive use. While many of these obstacles pertain
to lack of access or knowledge about methods; social
norms, provider misinformation and biases and expecta-
tions of adolescents can also be barriers to use [3–5].
Additionally, while an adolescent may want to space or
delay pregnancy, in some settings, early marriage may
mean that pregnancy is expected during adolescence. In-
terventions need to address the barriers adolescents face
at the community, facility and individual levels. For ex-
ample, at the community level, adolescents may want to
“prove” their fertility or solidify a relationship with a
pregnancy. Provider misperceptions regarding the safety
or need for contraception by adolescents are barriers at
the facility level [6] The adolescent herself may have
fears or misunderstandings of the safety of contraception
[7].
Adolescents who have had one unintended pregnancy
are high risk for a rapid, repeat pregnancy (defined as a
subsequent pregnancy within two years). Reported rates
of rapid, repeat pregnancy among adolescents range
from 20–50 % [8–11]. For some young women, a second
pregnancy may be planned and desired. However, for
many adolescents the second pregnancy is unintended.
Contact with the health system for abortion, delivery
and postpartum care provides an opening to recognize
and respond to adolescent motivation to initiate contra-
ception. It is paramount that these opportunities,
whether part of routine or emergency care, are utilized
to provide life-saving contraceptive services However, in
many settings, the choice of methods is limited, and
counselling and method provision is inconsistent Evi-
dence suggests that postpartum and post-abortion use
of longer acting methods (e.g. intrauterine device (IUD)
and implants) is safe and effective [12–15], but often
underutilized in low- and middle-income settings.
These methods are also recommended for adolescents
[16, 17].
Multiple interventions have targeted adolescent rapid
repeat pregnancy. These interventions have included
contraceptive provision, educational interventions (health
education, HIV/STI prevention education, community
services, counselling only, health education plus
skills-building, faith based group or individual coun-
selling), contraception promotion (contraception-edu-
cation with or without contraception distribution) and
complex interventions that contain multiple compo-
nents [18–23]. However, definitive data on the effi-
cacy of these interventions is lacking, particularly in
developing countries.
There is an urgent need to provide guidance on effect-
ive strategies in developing countries that improve
contraceptive use by adolescents and increase young
women’s control over their reproductive health, in par-
ticular those at highest risk for unintended pregnancy
(postpartum or post abortion adolescents) [24]. The
Adolescent Health Experience after Abortion or Delivery
(AHEAD) trial aims to address this evidence gap around
effective interventions to avert rapid, repeat pregnancy
among adolescents.
Study objectives
Over three phases, in the AHEAD multi-country
trial, we will design, pilot, finalize and ultimately
evaluate an intervention targeted at reducing rapid
repeat unintended pregnancy. In this protocol, we
present the methods for the first phase: formative re-
search to identify key determinants of contraceptive
use and rapid, repeat unintended pregnancy among
adolescents.
Phase 1 has three objectives:
Objective 1: Identify key issues surrounding
contraceptive use and prevention of unintended rapid
repeat pregnancy (within two years).
Objective 2: Determine the current health sector and
community response to adolescent pregnancy including
resources available to adolescents.
Objective 3: Assess acceptability to adolescents and
providers of potential intervention strategies to address
unintended rapid, repeat pregnancy.
Methods
Study setting
Formative work will be carried out in each of the se-
lected countries. The determinants of adolescent
pregnancy are known to vary by context, and we
want to ensure that the formative phase captures the
range of barriers and enablers to effective adolescent
contraceptive use in different settings. Within each
country, sites will be selected based on volume and
populations of adolescents presenting at facilities.
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Study design
In order to meet the objectives of this formative phase,
we will conduct focus group discussions (FGDs) and key
informant interviews (KIs), described below. The FGDs
will be conducted by a trained focus group facilitator,
and interviews by a trained interviewer. The FGDs will
also be attended by a trained note taker, making notes of
particular nonverbal cues or body language that could
inform analysis. The FGDs will be conducted in the par-
ticipants’ native languages. With consent, we will digit-
ally record all interviews and then the transcripts will be
translated and transcribed to English.
Focus group discussions
Participants of the FGDs are the target group of the
planned intervention: adolescents who have been preg-
nant. The FGDs will explore barriers and facilitators to
using contraception; and what their preferred methods
of overcoming these barriers would be. Further key areas
to be explored in the qualitative part of the formative re-
search are adolescents’ perceptions of the services and
information they have received while utilizing these
services.
Key informant interviews
Key informant (KI) interviews will take place with vari-
ous cadres of healthcare providers, health and education
officials, members of key youth and health organizations
that work with adolescents. The focus of these KIs will
be on attitudes and beliefs about adolescent pregnancy
and barriers and facilitators contraceptive use. Addition-
ally, the KIs will also focus on obtaining their opinions,
thoughts and perceived acceptability of potential inter-
ventions to prevent rapid repeat pregnancy.
Study participants
We will recruit adolescents from health facilities. At the
time when they will be seeking abortion or delivery care,
they will be approached for potential participation.
Eligibility criteria for adolescents to participate in
FGDs will be as follows:
 Adolescent girls between the ages of 15–19
 Presenting at participating facilities for abortions or
delivery care
In settings where the intervention is likely to include
post-abortion and post-partum adolescents, we will con-
duct separate focus groups to cover both populations.
Local PIs and the study team will identify providers at
facilities, and the relevant holders that will be appropri-
ate for the KIs.
Participant recruitment
Recruitment will be based in facilities. Medical personnel
in the wards in the facilities will be sensitized to the
study and be asked to assist with recruitment. A re-
search assistant will be available at the facility to discuss
the study with any potentially eligible adolescents. The
research assistant will explain the study and invite the
adolescents to participate in a focus group at a later
date. Once the adolescent expresses interest in the focus
group, the research assistant will ask the adolescent for
her contact information so she can be notified of the
timing and the venue for the focus group. The contact
information will not be retained after the focus group,
and any adolescent who express concerned about being
contacted will not be invited to the focus group.
Potential key informants will be contacted by the re-
search assistants. Research assistants will describe the
study and invite participation. If the person agrees, a
mutually agreeable time and venue will be identified.
Participant consent
Prior to beginning FGDs and KIs, research staff will ob-
tain informed consent or assent from each participant.
As part of the consent process, participants will be given
more detailed information about the study background,
goals, and objectives. Participants will be told that par-
ticipation is free, voluntary, and confidential. All FGDs
and KIs will be digitally recorded.
Adolescents and key informants aged 18 years and
above will be asked to sign an informed consent but told
that their names will not be linked to any of the infor-
mation they provide, or written on any other form. Ado-
lescents between the ages of 15–17 will be required to
obtain parental or guardian consent from a parent or
caregiver prior to participation. In cases where the ado-
lescent has undergone an abortion and has not alerted a
parent, we will use the local IRB recommendations on
who should be allowed to give consent and whether the
adolescent herself can give assent. While the names of
participants will be recorded on the individual consent
and assent forms, they will not be written on any FGD
forms. During the conduct of the FGDs, participants will
be given a number rather than using names. There will
be no recorded linkage between the participants and
identifying information– anonymity of participants will
be preserved.
Sampling and allocation
We will use purposive sampling at selected facilities.
The adolescents recruited as FGD participants will be
separated into different discussion groups according to
whether their pregnancy ended in a termination or birth.
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Sample size calculation
A minimum of two focus groups of 6 to 10 adoles-
cents will be conducted per facility. Between four to
eight facilities per country will be selected. The num-
ber of focus groups may change slightly across all
sites in a selected country; if we continue to find new
information after two per facility, we may conduct
additional focus groups to ensure saturation. We will
also conduct between 10 and 15 KIs per country.
Study instruments
The focus group guide is vignette-based and the KI is
semi-structured. The FGDs will focus on the following
themes per participant category:
Focus group discussion guide for adolescents
 Reactions to adolescent pregnancy (adolescents,
partners, parents, health providers)
 Motivations for using or not using contraception
 Contraceptive methods available to adolescents and
their awareness of them
 Experiences and relationships with health services
 Review and ranking of the participants’ perceptions
of potential interventions to prevent unintended
repeat pregnancy
Key informant interviewer guides
 Reach of contraceptive services in the community,
particularly for adolescents
 Type and quality of consultations with adolescents
 Community attitudes toward having adolescent
pregnancy
 Recommendations to improve contraceptive services
 Exploration of interventions that could prevent
unintended repeat pregnancy
Data management
All FGDs and KIs will be conducted by trained re-
search assistants in the preferred language of the par-
ticipants. They will digitally recorded with the
participants’ permission. All recordings will be stored
locally on a secure server. Field notes will be trans-
formed into data documents within a day of the KI
or FGD. These notes, as well as transcriptions, will
be anonymized, and no identifying information will
be included in the notes.
Initially, KIs and FGDs will be transcribed verbatim
in the original language. Following this, an independ-
ent translator will translate them into English. Digital
versions of the transcripts will be kept for up to three
years using a cloud-based storage that is password
protected and only accessible by the local study team
for each site (PI and research assistants) and WHO
study team. The originals will be deleted off of the
audio recorders following a data check to make sure
the originals were uploaded to the cloud. No names
will be included with the recordings.
All data collection and storage will be undertaken
under the principle of strict confidentiality.
Analysis
Data analysis will be conducted concurrently with
data collection, to enable ending data collection at
the point of data saturation. As the intention is to in-
form the development of an intervention, the analysis
strategy must take this into account. Therefore, we
will use framework analysis as analysis method [25].
Framework analysis contains the following steps:
 Familiarisation
 Identifying a thematic framework
 Indexing
 Charting
 Mapping and interpretation
Although there are distinct steps in the analysis, the
analysis is iterative, going back and forth between the
different steps, ensuring that the analysis is grounded in
the data [25]. To start with, one analyst per team reads
and re-reads the transcripts, to become familiar with the
content. Thereafter, they will code the data, creating a
coding matrix. This matrix will be checked by another,
independent analyst, against the original transcripts. The
analyst then goes back to the transcript, after changes
have been made to the matrix, and codes transcripts ac-
cording to the coding matrix. As coding continues, cat-
egories are developed, which can then evolve into
themes.
The last two steps have also been described as de-
veloping descriptive and explanatory accounts of the
data [26]. To develop a descriptive account, the re-
searcher will write a description of the range of
codes, categories and themes emerging from the data.
This process requires constant referral to the original
transcripts, to ensure accuracy. The explanatory ac-
counts then involve making sense of the descriptive
accounts, and interpreting findings in the context of
literature from the systematic review, through com-
paring the concepts, codes and categories to existing
knowledge.
We will hold a qualitative workshop to help the re-
search assistants, PIs and team members be part of the
process of developing in the intervention and work on
peer-reviewed publications. WHO will co-host the work-
shop in collaboration with country teams.
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Ethics approval
The WHO HRP Review Panel on Research Projects
(RP2), comprised of a committee of external reviewers,
reviewed and approved the scientific and technical con-
tent of the study (protocol ID, A65984). We then ob-
tained ethics review and approval from the WHO
Research Ethics Review Committee (ERC).
Study timeline
The time frame for the formative research and the devel-
opment of the intervention is ten months. The prepar-
ation of tools for the formative phase and ethical review
is expected to take approximately eight months. The es-
timated length for the entirety of Phase 1 is 18 months.




Data collected will provide an in-depth knowledge of
barriers to contraceptive use by adolescents; determi-
nants of rapid, repeat, unintended pregnancy; and an as-
sessment of potential interventions to increase
contraceptive use among adolescents to prevent unin-
tended rapid repeat pregnancies (less than two years).
Additional anticipated outcomes are the identification of
key issues within the health facility that restrict access to
contraception for adolescents as well as an improved un-
derstanding of motivators and incentives for contracep-
tive behaviour change among adolescents and health
care providers.
The findings from this first formative phase will be
used to develop an intervention for preventing unin-
tended rapid, repeat pregnancy among adolescents. This
intervention will be piloted for feasibility and early proxy
measures of efficacy in Phase 2 of the AHEAD trial.
Contribution of the study to identifying and/or reducing
inequities in sexual and reproductive health care
This protocol describes the first phase of a larger trial
aiming to develop and test effectiveness of an interven-
tion to reduce unintended repeat pregnancy in adoles-
cent girls. The results of the trial are expected to benefit
adolescent girls’ empowerment, meeting their needs and
increasing their future prospects in life. It also will help
increasing their access to health care and effective coun-
selling for contraceptive choices.
Plans for dissemination of research findings
At the conclusion of the study, a report will be prepared
of the study findings. The report will be circulated to
stakeholders participating in the study; an address for
questions and follow-up will be included. Each primary
investigator will be responsible for communicating with
the sites regarding the findings. A formal manuscript
will be prepared for publication in a peer reviewed jour-
nal and presentation at relevant academic conferences.
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